Vinorelbine potently induces placental cell death, does not harm fertility and is a potential treatment for ectopic pregnancy
Biography
A/Prof Roxanne Hastie is an NHMRC Emerging Leader Fellow, a perinatal epidemiologist and laboratory-based scientist. Based at the Mercy Hospital for Women, Roxanne co-leads a growing cross disciplinary team that combines these fields to drive translational research aimed at improving the treatment and management of pregnancy complications.
Roxanne is passionate about improving maternal and child health globally, she holds an honorary position with the Uppsala University, Sweden and works closely with researchers from Scotland, South Africa, the Solomon Islands and Pakistan.
Her core research themes are 1) investigating the effects of commonly used medications on maternal and offspring outcomes, with focus on the treatment of mental illness during pregnancy, 2) identifying new therapeutics for preeclampsia and 3) driving research to improve maternal health in low resource settings.